This topic contains a solution. Click here to go to the answer

Author Question: While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the ... (Read 98 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the following information should the nurse provide as preprocedure teaching?
 
  Select all that apply.
  A)
  Once the procedure is begun, you must lie very still since they will be inserting a needle through the uterine wall.
  B)
  We will put you into the stirrups and dilate your cervix with a small catheter so that we can obtain a cord sample.
  C)
  During the procedure, an ultrasound will be utilized to guide the catheter into the correct position.
  D)
  We will send a sample of amniotic fluid to a regional medical center to have DNA tests performed for any genetic abnormality.

Question 2

While the nurse is educating a fellow nurse about some new research being developed to treat hepatitis C, specifically to identify disease-related drug targets on the cells, the nurse will be basing these data on which new technology finding?
 
  A)
  Recombinant DNA technology
  B)
  Haplotype mapping
  C)
  The human genome project
  D)
  Interference RNA (RNAi)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CharlieArnold

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Ans:
A, C

Feedback:

PUBS is an invasive diagnostic procedure that involves the transcutaneous insertion of a needle through the uterine wall and into the umbilical artery. It is performed under ultrasound guidance and can be done any time after 16 weeks of gestation. Amniocentesis is the withdrawal of a sample of amniotic fluid for abnormal fetal screening as well as for chromosomal analysis. In chorionic villus sampling, the transcervical approach may be used (answer B).

Answer to Question 2

Ans:
D

Feedback:

Pharmaceutical companies are using RNAi to identify disease-related drug targets. There is considerable interest in harnessing RNAi for therapeutic purposes, linking the treatment of HIV infection and hepatitis C.




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jun 25, 2018
Great answer, keep it coming :)


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

For a complete list of videos, visit our video library